Indiwell Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 26.01%
(FY 2020)
- Profit -0.38%
(FY 2020)
- Ebitda 3.99%
(FY 2020)
- Net Worth 34.80%
(FY 2020)
- Total Assets 35.26%
(FY 2020)
About Indiwell Pharmaceuticals
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Yashvant Khaire, Shankar Sonawane, and Yogesh Sonawane serve as directors at the Company.
- CIN/LLPIN
U51909MH2017PTC295665
- Company No.
295665
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Indiwell Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yashvant Khaire  | Director | 01-Jun-2017 | Current |
| Shankar Sonawane | Director | 01-Jun-2017 | Current |
| Yogesh Sonawane | Director | 01-Jun-2017 | Current |
Financial Performance of Indiwell Pharmaceuticals.
Indiwell Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 26.01% increase. The company also saw a slight decrease in profitability, with a 0.38% decrease in profit. The company's net worth Soared by an impressive increase of 34.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indiwell Pharmaceuticals?
Unlock access to Indiwell Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indiwell Pharmaceuticals?
Unlock and access historical data on people associated with Indiwell Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indiwell Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indiwell Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
